Anupam Jena

Department of Health Care Policy
Harvard Medical School
180 Longwood Avenue, Door A
Boston, MA 02115

E-Mail: EmailAddress: hidden: you can email any NBER-related person as first underscore last at nber dot org
NBER Program Affiliations: HC
NBER Affiliation: Faculty Research Fellow
Institutional Affiliation: Harvard University

NBER Working Papers and Publications

July 2019Is Great Information Good Enough? Evidence from Physicians as Patients
with Michael D. Frakes, Jonathan Gruber: w26038
February 2016Self-insuring against Liability Risk: Evidence from Physician Home Values in States with Unlimited Homestead Exemptions
with Eric Helland, Dan P. Ly, Seth A. Seabury: w22031
January 2014Does Medical Malpractice Law Improve Health Care Quality?
with Michael Frakes: w19841

Published: Michael Frakes & Anupam B. Jena, 2016. "Does medical malpractice law improve health care quality?," Journal of Public Economics, vol 143, pages 142-158.

April 2011The Pragmatist's Guide to Comparative Effectiveness Research
with Amitabh Chandra, Jonathan S. Skinner: w16990

Published: Amitabh Chandra & Anupam B. Jena & Jonathan S. Skinner, 2011. "The Pragmatist's Guide to Comparative Effectiveness Research," Journal of Economic Perspectives, American Economic Association, vol. 25(2), pages 27-46, Spring. citation courtesy of

December 2009An Economic Evaluation of the War on Cancer
with Eric C. Sun, Darius N. Lakdawalla, Carolina M. Reyes, Tomas J. Philipson, Dana P. Goldman: w15574

Published: Lakdawalla, Darius N. & Sun, Eric C. & Jena, Anupam B. & Reyes, Carolina M. & Goldman, Dana P. & Philipson, Tomas J., 2010. "An economic evaluation of the war on cancer," Journal of Health Economics, Elsevier, vol. 29(3), pages 333-346, May. citation courtesy of

June 2009Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption
with Tomas Philipson: w15032

Published: Journal of Health Economics Volume 32, Issue 1, January 2013, Pages 172–180 Cover image Endogenous cost-effectiveness analysis and health care technology adoption ☆ Anupam B. Jenaa, Tomas J. Philipsonb,

January 2009"Me-Too" Innovation in Pharmaceutical Markets
with John E. Calfee, Edward C. Mansley, Tomas J. Philipson
in Frontiers in Health Policy Research, volume 12, David Cutler, Alan Garber, and Dana Goldman, organizers
July 2008The Value of Life in General Equilibrium
with Casey Mulligan, Tomas J. Philipson, Eric Sun: w14157
February 2006Surplus Appropriation from R&D and Health Care Technology Assessment Procedures
with Tomas J. Philipson: w12016
January 2006Health Care, Technological Change, and Altruistic Consumption Externalities
with Tomas Philipson, Stephane Mechoulan: w11930

Published: Journal of Law and Economics Vol. 53, No. 3. The University of Chicago Press. August 2010

December 2005Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs
with Tomas J. Philipson: w11810

Published: Tomas Philipson & Anupam Jena, 2006. "Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs," Forum for Health Economics & Policy, Berkeley Electronic Press, vol. 0(1), pages 1005-1005. citation courtesy of

NBER Videos

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email:

Contact Us